Could This Drug Candidate Be a Winner for These 2 Big Pharma Stocks?

Could This Drug Candidate Be a Winner for These 2 Big Pharma Stocks?

Source: 
Motley Fool
snippet: 
  • Milvexian is a drug candidate under development by Bristol Myers and Johnson & Johnson.
  • In a phase 2 clinical trial, milvexian produced encouraging results in preventing strokes.
  • If approved, it could generate several billion dollars in annual revenue for the two companies.